Publications by authors named "Mark Wathen"

Claim this Profile
D
Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT).
Gregory Y H Lip, Albert L Waldo, John Ip, David T Martin, Malcolm M Bersohn, Mark Wathen

Am J Cardiol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices.
David T Martin, Malcolm M Bersohn, Albert L Waldo, Mark S Wathen, Wassim K Choucair

Eur Heart J· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining shock reduction strategies to enhance ICD therapy: a role for computer modeling.
Kent J Volosin, Derek V Exner, Mark S Wathen, Lou Sherfesee, Anthony P Scinicariello

J Cardiovasc Electrophysiol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients.
Michael O Sweeney, Lou Sherfesee, Paul J DeGroot, Mark S Wathen, Bruce L Wilkoff

Heart Rhythm· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between pacing site and induction or termination of sustained monomorphic ventricular tachycardia by antitachycardia pacing.
Raymond Yee, Ulrika Birgersdotter-Green, Paul Belk, Troy Jackson, Jill Christensen, Mark S Wathen

Pacing Clin Electrophysiol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study.
John Ip, Albert L Waldo, Gregory Y H Lip, Peter M Rothwell, David T Martin, Mark S Wathen

Am Heart J· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
Bruce L Wilkoff, Brian D Williamson, Richard S Stern, Stephen L Moore, Fei Lu, Mark S Wathen

J Am Coll Cardiol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implantable cardioverter defibrillator shock reduction using new antitachycardia pacing therapies.
Mark Wathen

Am Heart J· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of the Primary Prevention Parameters Evaluation (PREPARE) trial of implantable cardioverter defibrillators to reduce patient morbidity [NCT00279279].
Bruce L Wilkoff, Richard Stern, Brian Williamson, Mark Wathen, Keith Holloman

Trials· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators.
Alfred E Buxton, Michael O Sweeney, Mark S Wathen, Mark E Josephson, Mary F Otterness

J Am Coll Cardiol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial.
Michael O Sweeney, Mark S Wathen, Kent Volosin, Ismaile Abdalla, Paul J DeGroot

Circulation· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Images in cardiovascular medicine. Himalayan T waves in the congenital long-QT syndrome.
Dawood Darbar, Dan M Roden, Muhammed F Ali, Tao Yang, Mark S Wathen

Circulation· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results.
Mark S Wathen, Paul J DeGroot, Michael O Sweeney, Alice J Stark, Mary F Otterness

Circulation· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and characteristics of type-2 breaks in response to antitachycardia pacing therapy in implantable cardioverter defibrillator patients.
Vinod Sharma, Paul J DeGroot, Mark S Wathen

J Cardiovasc Electrophysiol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of late recurrence of intra-atrial reentry tachycardia after radiofrequency catheter ablation in patients with congenital heart disease.
Prince J Kannankeril, Mark E Anderson, Jeffrey N Rottman, Mark S Wathen, Frank A Fish

Am J Cardiol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis